Literature DB >> 19720501

Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia.

Yu-Chih Shen1, Ding-Lieh Liao, Jen-Yeu Chen, Ying-Chieh Wang, I-Ching Lai, Ying-Jay Liou, Yu-Jun Chen, Sy-Ueng Luu, Chia-Hsiang Chen.   

Abstract

Dysregulation of glutamate neurotransmission is implicated in the pathphysiology of schizophrenia. Vesicular glutamate transporters (VGLUTs) package glutamate into vesicles in the presynaptic terminal and regulate the release of glutamate. Abnormal VGLUT1 expression has been linked to schizophrenia in postmortem brain studies. The purpose of this study was to investigate the involvement of the human VGLUT1 in the susceptibility to schizophrenia. In this study, we searched for genetic variants in the putative core promoter region and 12 exons (including UTR ends) of the VGLUT1 gene using direct sequencing in a sample of Han Chinese schizophrenic patients (n=376) and non-psychotic controls (n=368) from Taiwan, and conducted a case-control association study. We identified two common SNPs (g.-248G>C (ss159695612) and c.2697C>A (rs1043558)) in the VGLUT1 gene. No differences in the allele and genotype frequencies were detected between the patients and control subjects. Besides, we identified eight patient-specific rare variants in 16 out of 376 patients, including two variants (g.-296A>G (ss159695611) and g.-32Cv>T (ss159695613)) at the core promoter region and 5'UTR, two missense variants (L516M (ss159695617) and P551S (ss159695618)) and three silent variants (E24E (ss159695614), L118L (ss159695615), and P133P (ss159695616)) at protein-coding regions, and one variant (c.2201G>A (ss159695619)) at the 3'UTR. No rare variants were found in 368 control subjects (4.3% versus 0, P=1.5x10(-5)). Although the functional significance of these rare variants remains to be characterized, our study may lend support to the multiple rare mutation hypothesis of schizophrenia, and may provide genetic clues to indicate the involvement of the glutamate transmission pathway in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720501     DOI: 10.1016/j.schres.2009.08.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  RIM1alpha and interacting proteins involved in presynaptic plasticity mediate prepulse inhibition and additional behaviors linked to schizophrenia.

Authors:  Jacqueline Blundell; Pascal S Kaeser; Thomas C Südhof; Craig M Powell
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

2.  The α-subunit of the trimeric GTPase Go2 regulates axonal growth.

Authors:  Jens Baron; Christian Blex; Astrid Rohrbeck; Sivarama Krishna Rachakonda; Lutz Birnbaumer; Gudrun Ahnert-Hilger; Irene Brunk
Journal:  J Neurochem       Date:  2013-02-03       Impact factor: 5.372

3.  Lentiviral delivery of a vesicular glutamate transporter 1 (VGLUT1)-targeting short hairpin RNA vector into the mouse hippocampus impairs cognition.

Authors:  Madeleine V King; Nisha Kurian; Si Qin; Nektaria Papadopoulou; Ben H C Westerink; Thomas I Cremers; Mark P Epping-Jordan; Emmanuel Le Poul; David E Ray; Kevin C F Fone; David A Kendall; Charles A Marsden; Tyson V Sharp
Journal:  Neuropsychopharmacology       Date:  2013-08-28       Impact factor: 7.853

Review 4.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

Review 5.  Genetic findings in sport-related concussions: potential for individualized medicine?

Authors:  Jane McDevitt; Evgeny Krynetskiy
Journal:  Concussion       Date:  2017-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.